I can't imagine this presentation would be happening if PBT2 is not progressing well.
"Prana to Present at Rodman & Renshaw 9th Annual Healthcare Conference
MELBOURNE, Australia – October 29, 2007: Prana Biotechnology Limited (NASDAQ: PRAN / ASX: PBT), a biopharmaceutical company focused on the research
and development of treatments for neurodegenerative disorders, today announced that the Company is scheduled to present at the Rodman & Renshaw 9th Annual Global Healthcare Conference, on November 5-7, in New York City.
Steve Targum, M.D., Chief Medical Advisor will give a presentation on November 7, at 3:00 p.m. EST on the Company’s lead product, PBT2, which is currently in a Phase IIa clinical trial for Alzheimer’s disease. The live presentation may be accessed at the Company’s website, www.pranabio.com or at http://wsw.com/webcast/rrshq12/pran.
A replay of the presentation will be archived for 90 days after the conference, at the same locations."
pbt2 progressing well
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.4¢ | 0.3¢ | $12.53K | 4.143M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 13926044 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 153031722 | 56 |
View Market Depth
| Last trade - 14.56pm 19/11/2024 (20 minute delay) ? |
| ATH (ASX) Chart |